<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Serum ferritin concentration had been known to represent the amount of total body iron and has been clinically used as a parameter to evaluate the iron storage pool in a whole body </plain></SENT>
<SENT sid="1" pm="."><plain>Glycosylated (secreted) and non-glycosylated (non-secreted) forms of serum ferritin (sFt) have been reported by others based on the difference in their affinity to concanavalin-A binding </plain></SENT>
<SENT sid="2" pm="."><plain>In this report, we assessed the amount of glycosylated serum ferritin (Glyco-sFt) and the ratio (%) of Glyco-sFt/in hematopoietic disorders including <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overloads</z:e> (n = 10), <z:hpo ids='HP_0001909'>leukemias</z:hpo> (n = 36), malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (n = 10), <z:hpo ids='HP_0006775'>multiple myelomas</z:hpo> (n = 3) and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (n = 12) </plain></SENT>
<SENT sid="3" pm="."><plain>A high percentage of Glyco-sFt was observed in <z:mpath ids='MPATH_458'>normal</z:mpath> healthy controls (n = 18, 78.1 +/- 7.4%) and <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron-overloads</z:e> (61.1 +/- 17.8%) as compared with that in <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e> (43.8 +/- 23.4%, p &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>The amount of Glyco-sFt in <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron-overloads</z:e> was higher than that in <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e> with hyperferritinemia (p &lt; 0.005) </plain></SENT>
<SENT sid="5" pm="."><plain>These data demonstrated that the same part of serum ferritin in <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e> was the non-secreted form and appeared to be derived from <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell lysis </plain></SENT>
<SENT sid="6" pm="."><plain>We conclude that assessment of Glyco-Ft is a useful parameter to distinguish <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron-overloads</z:e> from malignant hematopoietic disorders both displaying hyperferritinemia </plain></SENT>
</text></document>